Ipsen Balance Sheet Health
Financial Health criteria checks 6/6
Ipsen has a total shareholder equity of €4.2B and total debt of €840.3M, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are €6.8B and €2.6B respectively. Ipsen's EBIT is €1.0B making its interest coverage ratio 136.8. It has cash and short-term investments of €1.4B.
Key information
19.86%
Debt to equity ratio
€840.30m
Debt
| Interest coverage ratio | 136.8x |
| Cash | €1.45b |
| Equity | €4.23b |
| Total liabilities | €2.60b |
| Total assets | €6.83b |
Recent financial health updates
Ipsen (EPA:IPN) Seems To Use Debt Rather Sparingly
Oct 28
Is Ipsen (EPA:IPN) Using Too Much Debt?
Dec 24Recent updates
Ipsen (EPA:IPN) Seems To Use Debt Rather Sparingly
Oct 28Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 41%?
Sep 07Investors Interested In Ipsen S.A.'s (EPA:IPN) Earnings
Jul 13Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40
May 16Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's
Apr 29Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40
Apr 14
Cabometyx And Tovorafenib Approvals May Strengthen Oncology Portfolio In 2025
Expansion of Onivyde and new product approvals could significantly increase revenue and strengthen market positions in key medical segments.Ipsen's (EPA:IPN) Soft Earnings Don't Show The Whole Picture
Feb 21Is Ipsen S.A. (EPA:IPN) Trading At A 44% Discount?
Feb 14Pinning Down Ipsen S.A.'s (EPA:IPN) P/E Is Difficult Right Now
Jan 20Is Ipsen (EPA:IPN) Using Too Much Debt?
Dec 24Financial Position Analysis
Short Term Liabilities: IPN's short term assets (€2.8B) exceed its short term liabilities (€1.4B).
Long Term Liabilities: IPN's short term assets (€2.8B) exceed its long term liabilities (€1.2B).
Debt to Equity History and Analysis
Debt Level: IPN has more cash than its total debt.
Reducing Debt: IPN's debt to equity ratio has reduced from 57.8% to 19.9% over the past 5 years.
Debt Coverage: IPN's debt is well covered by operating cash flow (116.2%).
Interest Coverage: IPN's interest payments on its debt are well covered by EBIT (136.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 16:37 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ipsen S.A. is covered by 28 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Silver | Barclays |
| Charles Pitman | Barclays |
| Charles Pitman | Barclays |